These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27896495)

  • 1. Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography.
    Collet C; Sotomi Y; Cavalcante R; Asano T; Miyazaki Y; Tenekecioglu E; Kistlaar P; Zeng Y; Suwanasson P; de Winter RJ; Nieman K; Serruys PW; Onuma Y
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):431-439. PubMed ID: 27896495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds.
    Collet C; Chevalier B; Cequier A; Fajadet J; Dominici M; Helqvist S; Van Boven AJ; Dudek D; McClean D; Almeida M; Piek JJ; Tenekecioglu E; Bartorelli A; Windecker S; Serruys PW; Onuma Y
    JACC Cardiovasc Imaging; 2018 May; 11(5):722-732. PubMed ID: 28734923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
    Sotomi Y; Onuma Y; Suwannasom P; Tateishi H; Tenekecioglu E; Zeng Y; Cavalcante R; Jonker H; Dijkstra J; Foin N; Koon JN; Collet C; de Winter RJ; Wykrzykowska JJ; Stone GW; Popma JJ; Kozuma K; Tanabe K; Serruys PW; Kimura T
    EuroIntervention; 2016 Oct; 12(8):e998-e1008. PubMed ID: 27721215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities.
    Simsek C; Karanasos A; Magro M; Garcia-Garcia HM; Onuma Y; Regar E; Boersma E; Serruys PW; van Geuns RJ
    EuroIntervention; 2016 Jan; 11(9):996-1003. PubMed ID: 25349042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
    Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
    EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation: A Randomized Controlled Trial.
    Lee SY; Kang DY; Hong SJ; Ahn JM; Ahn CM; Park DW; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008383. PubMed ID: 32525410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo coronary lesion differentiation with computed tomography angiography and intravascular ultrasound as compared to optical coherence tomography.
    Wieringa WG; Lexis CP; Lipsic E; van der Werf HW; Burgerhof JG; Hagens VE; Bartels GL; Broersen A; Schurer RA; Tan ES; van der Harst P; van den Heuvel AF; Willems TP; Pundziute G
    J Cardiovasc Comput Tomogr; 2017; 11(2):111-118. PubMed ID: 28169175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries.
    Zeng Y; Tateishi H; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Nie S; Jonker H; Dijkstra J; Radu MD; Räber L; McClean DR; van Geuns RJ; Christiansen EH; Fahrni T; Koolen J; Onuma Y; Bruining N; Serruys PW
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1151-1161. PubMed ID: 28330651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.
    Paradies V; Smits PC; Vachojannis GJ; Royaards KJ; Wassing J; van der Ent M
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):279-285. PubMed ID: 29066339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.
    Maeremans J; Verhaert D; Pereira B; Frambach P; Van Mieghem C; Barbato E; Willems E; Vrolix M; Dens J
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):488-496. PubMed ID: 29068171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
    Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT-assessment of scaffold resorption: Analysis of strut intensity by a new resorption index for poly-l-lactic acid bioresorbable vascular scaffolds.
    Blachutzik F; Achenbach S; Marwan M; Tröbs M; Boeder N; Doerr O; Weissner M; Bauer T; Nef H; Hamm C; Schlundt C
    Catheter Cardiovasc Interv; 2019 Dec; 94(7):928-935. PubMed ID: 30945432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.